The Association of the British Pharmaceutical Industry
The Association of the British Pharmaceutical Industry (ABPI) is the UK trade association representing research-based pharmaceutical companies, administering the industry Code of Practice and Disclosure UK transparency database while engaging government and NHS bodies on medicine pricing, regulation, and access.
- Company typePrivate
- Founded1891
- HeadquartersLondon, United Kingdom
- Headcount51–100
- GTM typeB2B
- OfferingServices
What The Association of the British Pharmaceutical Industry does
The Association of the British Pharmaceutical Industry (ABPI) is a UK trade association founded in 1891, headquartered in London, and structured as a company limited by guarantee with 51-100 employees. It represents innovative research-based pharmaceutical companies — large, medium, and small — operating in the UK market. ABPI serves as the industry's collective voice on policy, regulation, pricing, and market access, engaging directly with the Department of Health and Social Care, NHS England, NICE, MHRA, and other government and regulatory bodies.
ABPI's core offerings span self-regulation, transparency, patient involvement, and industry coordination. The ABPI Code of Practice, administered through the independent Prescription Medicines Code of Practice Authority (PMCPA), governs pharmaceutical industry promotion and interactions with healthcare professionals and patient organisations. Disclosure UK is a publicly accessible database (now in its 11th year) recording payments and benefits-in-kind from pharmaceutical companies to healthcare professionals and organisations. Additional programmes include the Patient Organisation Forum and Patient Advisory Council, NHS-Industry Partnership Case Studies, the Pharmaceutical Impact Map, UK Pharma Reputation Index, ABPI Medical Representatives Exam, and annual events such as the ABPI Conference, Industry Summit, and Regulatory Science Symposium.
ABPI generates revenue through membership fees paid by pharmaceutical company members, operating on a subscription/recurring model. As a trade association rather than a product company, ABPI does not sell to end customers; its value proposition centers on industry representation, regulatory negotiation (including the Voluntary Scheme for Branded Medicines Pricing), clinical research promotion, supply chain resilience advocacy, and convening multi-stakeholder forums across the UK pharmaceutical ecosystem.
The Association of the British Pharmaceutical Industry firmographics
Firmographics- Name
- The Association of the British Pharmaceutical Industry
- Legal name
- The Association of the British Pharmaceutical Industry
- Website
- https://abpi.org.uk
- Company type
- Private
- Founded year
- 1891
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- The Association of the British Pharmaceutical Industry (ABPI) is the UK trade association representing research-based pharmaceutical companies, administering the industry Code of Practice and Disclosure UK transparency database while engaging government and NHS bodies on medicine pricing, regulation, and access.
- Ownership category
- akta.pro rank
The Association of the British Pharmaceutical Industry industry classification
Industry- Product category
- Pharmaceutical Trade Association
- akta.pro primary industry
- Health, Pharmaceuticals & Medical Devices Regulatory Cooperation (BPADANAJ)
- akta.pro secondary industries
- Fraud Risk Management & Anti-Bribery/Anti-Corruption (ABAC) (BPAHAFAL), Pharmacovigilance, Risk Management & Medical Affairs CROs (HLAGAAAH), Clinical Trial Pharmacy & IMP Management at Site (HLAGACAK)
Keywords
Where The Association of the British Pharmaceutical Industry is headquartered
LocationHeadquarters
- HQ city
- London
- HQ country
- United Kingdom
- HQ region
- Europe
Offices2 records
Markets served
The Association of the British Pharmaceutical Industry business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D
Revenue model
- Membership Fees: ABPI operates as a membership organization for pharmaceutical companies. Membership fees fund the association's operations, policy work, and industry representation activities.
Distribution channels3 records
Marketing channels6 records
The Association of the British Pharmaceutical Industry product offering
Product offeringCore offering
The Association of the British Pharmaceutical Industry (ABPI) is a UK trade association representing innovative research-based pharmaceutical companies. It delivers industry advocacy, regulatory representation, and self-regulatory oversight through the ABPI Code of Practice, Disclosure UK transparency database, and structured engagement with government and the NHS on medicine pricing, supply chain resilience, and clinical research.
Product overview
The ABPI operates as a trade association representing innovative research-based biopharmaceutical companies in the UK. Rather than offering a unified software product, the ABPI provides a portfolio of industry programmes, transparency initiatives, publications, and professional services. The core offerings include the ABPI Code of Practice and Disclosure UK database (which together form the industry's self-regulatory framework and transparency initiative), patient involvement programmes (Patient Advisory Council and Patient Organisation Forum), NHS-industry partnership resources (case study libraries and collaborative frameworks), and events (annual conference, industry summit, and regulatory science symposium). The ABPI also publishes authoritative guides and reports including the 'guide to the development and manufacture of medicines' and the 'resilient medicines supply chain' report. Additional resources include the Pharmaceutical Impact Map (data visualisation tool), UK Pharma Reputation Index, comprehensive glossary, and professional certification (ABPI Exam for medical representatives). The organisation serves its members through membership services, leadership resources, and working groups across topics including international trade, intellectual property, health data, vaccines, and antimicrobial resistance.
Differentiator
Problem solved
Functional benefit
Products and services
- Disclosure UK Publicly accessible database that records payments and benefits-in-kind made by pharmaceutical companies to healthcare professionals and healthcare organisations, promoting industry transparency under the ABPI Code of Practice.
- ABPI Code of Practice Industry self-regulatory code setting requirements the pharmaceutical industry must comply with, governing promotion of medicines to healthcare professionals and interactions between pharmaceutical companies, healthcare professionals and patient organisations. Administered by PMCPA.
- ABPI Medical Representatives Exam Professional examination for medical representatives, ensuring they meet industry standards for knowledge and conduct as part of the ABPI's reputation and standards programme.
- ABPI Patient Advisory Council Council comprising patient advocates that provides strategic counsel and patient input into ABPI activities, supporting equitable access to research and innovation for UK patients.
- ABPI Patient Organisation Forum Networking forum hosted by ABPI for registered patient and health charities to engage with pharmaceutical companies, with a shared goal of supporting equitable access to research and innovation for UK patients.
Quantifiable outcome
- £17.6bn direct GVA contribution to UK economy
- +3 more outcomes
Companies that use The Association of the British Pharmaceutical Industry
Customer profileNamed customers1 record
Segments5 records
Ideal customer profiles3 records
The Association of the British Pharmaceutical Industry technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
Feature3 records
The Association of the British Pharmaceutical Industry partnerships and signals
Strategic signalPartnerships
17 partnerships are on record, tiered core and major.
- Department of Health and Social Care (DHSC)coreDHSC is a key government partner negotiating the Voluntary Scheme for Branded Medicines Pricing and Access (VPAG). ABPI works with DHSC on medicines pricing, supply chain policy, and pharmaceutical regulation.
- NHS EnglandcoreABPI collaborates with NHS England on medicine access, clinical research, NHS-Industry Partnership Case Studies, and manages access arrangements including Cancer Drugs Fund and Innovative Medicines Fund.
- National Institute for Health and Care Excellence (NICE)coreNICE conducts health technology assessments for medicines; ABPI engages with NICE on methods evolution and patient access to combination therapies.
- Medicines and Healthcare products Regulatory Agency (MHRA)coreMHRA is the UK regulator for medicines; ABPI works with MHRA on regulatory science, marketing authorizations, and medicine supply during disruptions.
- Health Research Authority (HRA)coreHRA coordinates research ethics committees for clinical trials; ABPI collaborates with HRA to support ethical clinical research in the UK NHS.
- National Institute for Health and Care Research (NIHR)coreNIHR funds health research in England; ABPI works with NIHR on clinical trials and research infrastructure supporting industry studies.
- Prescription Medicines Code of Practice Authority (PMCPA)corePMCPA is the independent body that administers the ABPI Code of Practice for the Pharmaceutical Industry, handling complaints and publishing rulings.
- Accelerated Access Collaborative (AAC)majorNHS England body bringing together health system and industry to speed up patient access to innovative medicines; ABPI participates in AAC initiatives.
- Patient OrganisationsmajorABPI hosts Patient Organisation Forum for registered patient and health charities to network, learn and engage with pharmaceutical companies. Includes ABPI Patient Advisory Council.
- Academy of Medical Royal Colleges (AoMRC)majorBody coordinating medical royal colleges across UK and Ireland; ABPI collaborates on improving medical standards and quality of patient care.
- Healthcare Distribution Association (HDA UK)majorABPI works with HDA UK on medicines supply chain resilience, working with wholesalers to ensure fair distribution during disruptions.
- Cell and Gene Therapy CatapultmajorIndependent innovation organization advancing cell and gene therapies; ABPI collaborates on ATMP development and patient access.
- Genomics EnglandmajorGovernment company analyzing genomes for NHS; ABPI works with Genomics England on genomic medicine research.
- UK BiobankmajorMajor biomedical database with genetic and health data from 500,000 UK participants; ABPI supports research using this data asset.
- NHS Procurement and Supply Chain TeamscoreABPI member companies work closely with NHS procurement specialists on medicine supply management, stock allocation during shortages, and hospital-level distribution decisions.
- WholesalerscorePharmaceutical companies work with wholesalers for national medicine distribution. Wholesalers often spot issues early and support pharmacies with alternatives during supply disruptions.
- ABPI Member CompaniescoreABPI represents pharmaceutical company members including innovative research-based biopharmaceutical companies, large, medium and small, operating in the UK.
Scale indicators15 records
Recent moves6 records
Expansion highlights5 records
The Association of the British Pharmaceutical Industry competitors and assessment
Company assessmentOthers
- NHS Confederation: NHS Confederation represents NHS organisations and engages with the pharmaceutical industry on access, pricing, and innovation matters; a complementary stakeholder rather than a peer in industry representation.
- Prescription Medicines Code of Practice Authority: PMCPA is the independent body established by ABPI to administer the ABPI Code of Practice; functionally a subsidiary governance operation rather than an external peer.
Regional players
- Pharmaceutical Research and Manufacturers of America: PhRMA is the US equivalent innovative pharma trade association, performing comparable advocacy, PhRMA Code administration, and federal policy engagement for US-based pharmaceutical companies.
- Medicines Australia: Medicines Australia is the Australian equivalent pharma trade association, performing comparable advocacy, Code of Conduct administration, and member services for research-based pharma companies in Australia.
- Bundesverband der Pharmazeutischen Industrie: BPI is the German pharmaceutical industry trade association, comparable in representing pharma manufacturers and engaging with government on regulatory and pricing matters in Germany.
- Biotechnology Innovation Organization: BIO is the US trade association for the biotechnology industry, providing analogous advocacy and policy engagement for innovative biopharmaceutical companies, with broader remit including smaller biotechs than ABPI.
- Japan Pharmaceutical Manufacturers Association: JPMA is the Japanese innovative pharma trade association, comparable in representing research-based pharmaceutical companies and engaging government on pricing, regulation, and R&D policy.
Direct peers
- International Federation of Pharmaceutical Manufacturers and Associations: IFPMA is the global pharmaceutical industry federation of which ABPI is a member; performs comparable advocacy and Code-administration functions at global level including WHO engagement.
- European Federation of Pharmaceutical Industries and Associations: EFPIA is ABPI's direct EU-level counterpart, performing analogous advocacy, policy work, and regulatory engagement for innovative pharmaceutical companies across EU institutions; ABPI is itself an EFPIA member.
Emerging players
- BioIndustry Association: BIA is the UK trade association for biotech and emerging life sciences companies, operating alongside ABPI in the UK ecosystem with focus on smaller and earlier-stage companies rather than large research-based pharma.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
The Association of the British Pharmaceutical Industry social profiles
Digital presenceThe Association of the British Pharmaceutical Industry compliance and trust
Trust signalCompliance1 record
The Association of the British Pharmaceutical Industry financial estimates
Financial estimateRevenue estimate
Valuation estimate
The Association of the British Pharmaceutical Industry leadership team
Management profileNumber of profiles
Profiles1 record
The Association of the British Pharmaceutical Industry funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
The Association of the British Pharmaceutical Industry M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about The Association of the British Pharmaceutical Industry
What does The Association of the British Pharmaceutical Industry do?
The Association of the British Pharmaceutical Industry (ABPI) is a UK trade association representing innovative research-based pharmaceutical companies. It delivers industry advocacy, regulatory representation, and self-regulatory oversight through the ABPI Code of Practice, Disclosure UK transparency database, and structured engagement with government and the NHS on medicine pricing, supply chain resilience, and clinical research.
Is The Association of the British Pharmaceutical Industry a public or private company?
The Association of the British Pharmaceutical Industry is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was The Association of the British Pharmaceutical Industry founded?
The Association of the British Pharmaceutical Industry was founded in 1891. It employs 51 to 100 people.
Where is The Association of the British Pharmaceutical Industry based?
The Association of the British Pharmaceutical Industry is headquartered in London, United Kingdom, in the Europe region.
How does The Association of the British Pharmaceutical Industry make money?
One revenue line is on record: membership Fees.
Who are The Association of the British Pharmaceutical Industry's main competitors?
Others on record are NHS Confederation and Prescription Medicines Code of Practice Authority. Regional players are Pharmaceutical Research and Manufacturers of America, Medicines Australia, Bundesverband der Pharmazeutischen Industrie, Biotechnology Innovation Organization and Japan Pharmaceutical Manufacturers Association. Direct peers are International Federation of Pharmaceutical Manufacturers and Associations and European Federation of Pharmaceutical Industries and Associations. BioIndustry Association is listed as an emerging player.
Does The Association of the British Pharmaceutical Industry have an API?
No public API is recorded for The Association of the British Pharmaceutical Industry.
What industry is The Association of the British Pharmaceutical Industry in?
The Association of the British Pharmaceutical Industry's product category is Pharmaceutical Trade Association. Its primary akta.pro industry code is BPADANAJ, Health, Pharmaceuticals & Medical Devices Regulatory Cooperation, with a secondary code of BPAHAFAL, Fraud Risk Management & Anti-Bribery/Anti-Corruption (ABAC).